Notice Of Intent Not A Part Of MCAC Executive Committee Meeting Agenda
This article was originally published in The Gray Sheet
Executive Summary
The executive committee of the Medicare Coverage Advisory Committee likely will not discuss at its June 6 meeting the Health Care Financing Administration's recently released "notice of intent" on Medicare coverage criteria.
You may also be interested in...
HCFA Criteria For Medicare Coverage Likely To Rekindle Cost Debate
The Health Care Financing Administration's "notice of intent" on Medicare coverage criteria proposes to consider cost as a factor in the agency's decision-making, but leaves the extent to which it would be used largely undefined.
MCAC Panel Process Concerns Derail Ratification Of Initial Coverage Opinions
Standard procedures for conducting Medicare Coverage Advisory Committee panel reviews must be developed if future panel recommendations are to hold any chance of ratification, several members of MCAC's Executive Committee maintained at a Dec. 8 meeting.
Woodcock Takes On Rare Disease Challenges In Retirement, Keeps FDA, Industry At Arm’s Length
Recently retired US FDA Principal Deputy Commissioner Janet Woodcock will be advising the Haystack Project, with the goal of helping rare disease organizations encourage creativity in drug development programs without jeopardizing regulatory success, Woodcock told the Pink Sheet in an interview.